Column Capital Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$13.4K Hold
249
﹤0.01% 486
2023
Q2
$13.4K Hold
249
﹤0.01% 487
2023
Q1
$13.6K Hold
249
﹤0.01% 497
2022
Q4
$12.1K Sell
249
-329
-57% -$14.4K ﹤0.01% 490
2022
Q3
$22K Sell
578
-382
-40% -$17K ﹤0.01% 376
2022
Q2
$48K Hold
960
0.01% 287
2022
Q1
$49K Sell
960
-39
-4% -$2.01K 0.01% 293
2021
Q4
$50K Buy
999
+88
+10% +$4.35K 0.01% 296
2021
Q3
$44K Hold
911
0.01% 287
2021
Q2
$48K Buy
911
+60
+7% +$3.13K 0.01% 280
2021
Q1
$42K Hold
851
0.01% 296
2020
Q4
$41K Hold
851
0.01% 300
2020
Q3
$43K Hold
851
0.01% 270
2020
Q2
$43K Hold
851
0.01% 274
2020
Q1
$37K Hold
851
0.02% 242
2019
Q4
$42K Buy
+851
New +$39.9K 0.02% 266

Other funds holding SNY

Column Capital Advisors's SNY Position: Q3 2023 in Review

Column Capital Advisors held its Sanofi (SNY) position steady in Q3 2023 at 249 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Column Capital Advisors first reported a position in SNY in Q4 2019 and has held it in 16 quarters since. The position peaked at $50K in Q4 2021. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • Column Capital Advisors held 249 shares of Sanofi worth $13.4K as of Q3 2023.
  • Column Capital Advisors left its Sanofi share count unchanged in Q3 2023.
  • Sanofi made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #486 holding.
  • Column Capital Advisors first reported a position in Sanofi in Q4 2019 and has held it in 16 quarters since.
  • Column Capital Advisors's Sanofi position peaked at $50K in Q4 2021.
  • 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.